AKEBIA THERAPEUTICS, INC. Assets, Fair Value Disclosure
AKEBIA THERAPEUTICS, INC. (AKBA) had Assets, Fair Value Disclosure of $157.47 million as of 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Notes › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2015-11-09
- 2015-09-30: Assets, Fair Value Disclosure $157.47M.
- 2015-06-30: Assets, Fair Value Disclosure $152.79M.
- 2015-03-31: Assets, Fair Value Disclosure $100.33K.
- 2014-12-31: Assets, Fair Value Disclosure $108.92M; Assets, Fair Value Disclosure as first filed $108.92M.
| Period end | Assets, Fair Value Disclosure | Assets, Fair Value Disclosure as first filed |
|---|---|---|
| 2015-09-30 | $157.47M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $152.79M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $100.33K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $108.92M 10-Q · filed 2015-11-09 | $108.92M 10-K · filed 2015-03-04 |
| 2014-09-30 | $118.34M 10-Q · filed 2014-11-10 | |
| 2013-12-31 | $32.56M 10-K · filed 2015-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |